Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,641 | 115,565 | 44,006 | 196,554 | 319,832 |
| Marketable Securities | 232,551 | 175,319 | 229,273 | 115,825 | 31,024 |
| TOTAL | $351,171 | $296,642 | $278,603 | $317,807 | $355,923 |
| Non-Current Assets | |||||
| PPE Net | 34 | 50 | 61 | 72 | 185 |
| Investments And Advances | 17,272 | 10,717 | 1,614 | 1,835 | 0 |
| Other Non-Current Assets | 15,163 | 14,609 | 12,807 | 14,052 | 13,860 |
| TOTAL | $32,469 | $25,376 | $14,482 | $15,959 | $14,045 |
| Total Assets | $383,640 | $322,018 | $293,085 | $333,766 | $369,968 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,111 | 6,444 | 7,931 | 20,018 | 17,136 |
| Accrued Expenses | 54,423 | 45,359 | 44,520 | 28,206 | 39,371 |
| TOTAL | $62,649 | $52,421 | $53,244 | $49,132 | $57,292 |
| Non-Current Liabilities | |||||
| Long Term Debt | 78,636 | 72,989 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 211 | 180 | 215 | 317 | 218 |
| TOTAL | $78,847 | $73,169 | $215 | $317 | $218 |
| Total Liabilities | $141,496 | $125,590 | $53,459 | $49,449 | $57,510 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,361 | 53,679 | 42,110 | 41,834 | 41,799 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -765,128 | -524,686 | -473,187 | -420,964 | -387,391 |
| Other shareholders' equity | -64 | -69 | -94 | 141 | 194 |
| TOTAL | $242,144 | $196,428 | $239,626 | $284,317 | $312,458 |
| Total Liabilities And Equity | $383,640 | $322,018 | $293,085 | $333,766 | $369,968 |